Clinical Trial: Integrating HER2 PET/CT and Multi-Omics Data to Construct an ADC Efficacy Prediction Model for Precision Treatment of Breast Cancer (China)

China, Sept. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Integrating HER2 PET/CT and Multi-Omics Data to Construct an ADC Efficacy Prediction Model for Precision Treatment of Breast Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133210

Registration Time: 2026/09/23

Type: Interventional study

Primary Sponsor: Beijing Cancer Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344854

Published by HT Digital Content Services with permission from Health Daily Digest....